
GC70179
α7 Nicotinic receptor agonist-1
Also known as spiro[1-azabicyclo[2.2.2]octane-3,2'-3H-furo[2,3-b]pyridine]-5'-amine
Alpha-7 Nicotinic receptor agonist-1 (Preparation 5) is an alpha-7 nAChR agonist· It can be used for research on psychiatric disorders such as schizophrenia, mania or bipolar disorder, and anxiety disorders, as well as intellectual disabilities such as Alzheimer's disease, learning deficits, cognitive impairments, attention deficits, memory loss, Lewy body dementia and attention deficit hyperactivity disorder
ChemicalCAS220100-05-0MW231.29FormulaC13H17N3O
- CAS number
- 220100-05-0
- Molecular weight
- 231.29
- Formula
- C13H17N3O
- Solubility
- DMSO : 100 mg/mL (432·36 mM; Need ultrasonic)
- InChIKey
- SWFYVZKNABTMPR-UHFFFAOYSA-N
- Catalogue number
- GC70179
- Brand
- GLPBIO
Computed properties PubChem CID 15908236 · XLogP 1 · TPSA 51.4 Ų · H-bond donors 1
- XLogP
- 1
- TPSA
- 51.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 0
- Heavy atoms
- 17
SMILES C1CN2CCC1C3(C2)CC4=C(O3)N=CC(=C4)N
Computed descriptors from PubChem (CID 15908236), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il